Share this:

Nov 25, 2013 · Leave a Reply

First-in-humans study introduces next generation cell therapy

By Center for Regenerative Medicine @centerforregmedmc

Translating a Mayo Clinic stem-cell discovery, an international team has demonstrated that therapy with cardiopoietic (cardiogenically-instructed) or "smart" stem cells can improve heart health for people suffering from heart failure. This is the first application in patients of lineage-guided stem cells for targeted regeneration of a failing organ, paving the way to development of next generation regenerative medicine solutions. Results of the clinical trial appear online in the Journal of the American College of Cardiology.

Read more in Mayo’s Discovery’s Edge magazine and watch a video describing the research:

 http://www.youtube.com/watch?v=vumB_FW_fTA&list=PLSWR1ylG_6JbkP1eX_IvjzD_uDYrftp-z

Tags: Andre Terzic, C-CURE, cardiac, Cardio3, Mayo Clinic, regenerative medicine, stem cells, Uncategorized

Please login or become a member to post a comment.

Contact Us · Privacy Policy